Cargando…
Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study
Parkinson's disease (PD) affects millions of individuals worldwide, and it is the second most common late-onset neurodegenerative disorder. There is no cure and current treatments only alleviate symptoms. Modifiable risk factors have been explored as possible options for decreasing risk or deve...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477004/ https://www.ncbi.nlm.nih.gov/pubmed/36119674 http://dx.doi.org/10.3389/fneur.2022.940118 |